Methylated genes other than CDK2NA and DPYSL3 may be implicated in an unfavourable prognosis of NBNC-HCC complicated with T2D, particularly because a recent genome-wide study showed PM of several tumour suppresser genes implicated in the tumorigenesis of NBNC-HCC50. This evidence concerns the gene DPYSL3 and type 2 diabetes mellitus.